82378-86-7

Basic information

• Product Name: 4-Amino-1-benzyl-3-methylpiperidine
• Synonyms: 4-Amino-1-benzyl-3-methylpiperidine;4-PiperidinaMine, 3-Methyl-1-(phenylMethyl)-;1-benzyl-3-Methylpiperidin-4-aMine;1-Benzyl-3-methylpiperidin-4-ylamine
• CAS NO: 82378-86-7
• Molecular Formula: C₁₃H₂₀N₂
• Molecular Weight: 204.32
• Product Categories: pharmacetical
• Mol File: 82378-86-7.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 291.136 °C at 760 mmHg
• Flash Point: 120.985 °C
• Appearance: /
• Density: 1.005 g/cm³
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.542
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-Amino-1-benzyl-3-methylpiperidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Amino-1-benzyl-3-methylpiperidine(82378-86-7)
• EPA Substance Registry System: 4-Amino-1-benzyl-3-methylpiperidine(82378-86-7)

Safety Data

• Hazardous Substances Data: 82378-86-7(Hazardous Substances Data)

Usage

General Description

4-Amino-1-benzyl-3-methylpiperidine, also known as MMDA, is a synthetic chemical compound that belongs to the piperidine class of chemicals. It is an analogue of the hallucinogenic drug MDMA (Ecstasy) and possesses psychoactive properties. MMDA is known to act as a serotonin and norepinephrine reuptake inhibitor, and it also affects the release of these neurotransmitters in the brain. It has been studied for its potential as a therapeutic agent for conditions such as depression and anxiety, as well as for its recreational use. However,

InChI:InChI=1/C13H20N2/c1-11-9-15(8-7-13(11)14)10-12-5-3-2-4-6-12/h2-6,11,13H,7-10,14H2,1H3

Upstream product

• 34737-89-8 1-Benzyl-3-methyl-4-piperidon 

Relevant articles and documents

Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments

This invention relates to new generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, to their optical isomers, diastereomers or enantiomers, as well as pharmaceutically acceptable salts, hydrates, prodrugs, polymorphs and pseudopolymorphs thereof, to their preparation, to their compositions and to their use.

2-oxoimidazole derivatives

The present invention relates to a compound represented by Formula [I] wherein represents an aromatic carbo- or heterocyclic ring which may have a substituent; Cy represents a mono-, bi- or tricyclic aliphatic carbocyclic group having 3 to 20 carbon atoms, which may have a substituent; represents a mono- or bicyclic aliphatic nitrogen-containing heterocyclic group having 3 to 14 carbon atoms, which may have a substituent; R1represents a hydrogen atom, a lower alkenyl group, a lower alkynyl group, a cyclo(lower alkyl) group, an amino group, a lower alkylamino group, a di(lower alkyl)-amino group, a hydroxyl group, a lower alkoxy group, a carboxyl group, a lower alkoxycarbonyl group, a carbamoyl group, a lower alkylcarbamoyl group or a di(lower alkyl)carbamoyl group, or a lower alkyl group which may have a substituent; and R2represents a hydrogen atom or a lower alkyl group, a salt or ester thereof, a production process for the same, and an analgesic, a reliever against tolerance to a narcotic analgesic represented by morphine, a reliever against dependence on a narcotic analgesic represented by morphine, an analgesic enhancer, an antiobestic, a drug for ameliorating brain function, a remedy for schizophrenia, a remedy for Parkinsonism, a remedy for chorea, an antidepressant, a remedy for diabetes insipidus, a remedy for polyuria, or a remedy for hypotension, comprising an effective ingredient of the same.